Your browser doesn't support javascript.
loading
Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import.
Rodriguez-Bravo, Veronica; Pippa, Raffaella; Song, Won-Min; Carceles-Cordon, Marc; Dominguez-Andres, Ana; Fujiwara, Naoto; Woo, Jungreem; Koh, Anna P; Ertel, Adam; Lokareddy, Ravi K; Cuesta-Dominguez, Alvaro; Kim, Rosa S; Rodriguez-Fernandez, Irene; Li, Peiyao; Gordon, Ronald; Hirschfield, Hadassa; Prats, Josep M; Reddy, E Premkumar; Fatatis, Alessandro; Petrylak, Daniel P; Gomella, Leonard; Kelly, W Kevin; Lowe, Scott W; Knudsen, Karen E; Galsky, Matthew D; Cingolani, Gino; Lujambio, Amaia; Hoshida, Yujin; Domingo-Domenech, Josep.
Afiliação
  • Rodriguez-Bravo V; Cancer Biology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA; Medical Oncology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA; Pathology Department, Icahn School of Medicine at Mount Sinai, New Yor
  • Pippa R; Cancer Biology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA; Medical Oncology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA; Pathology Department, Icahn School of Medicine at Mount Sinai, New Yor
  • Song WM; Genetic and Genomic Sciences Department. Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Carceles-Cordon M; Pathology Department, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Dominguez-Andres A; Cancer Biology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA; Medical Oncology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA; Pathology Department, Icahn School of Medicine at Mount Sinai, New Yor
  • Fujiwara N; Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Woo J; Cancer Biology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA; Medical Oncology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA; Pathology Department, Icahn School of Medicine at Mount Sinai, New Yor
  • Koh AP; Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Ertel A; Cancer Biology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Lokareddy RK; Department of Biochemistry and Molecular Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Cuesta-Dominguez A; Oncological Sciences Department. Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Division of Liver Diseases, Medicine Department, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Kim RS; Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Rodriguez-Fernandez I; Pathology Department, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Li P; Cancer Biology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA; Medical Oncology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Gordon R; Pathology Department, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Hirschfield H; Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Prats JM; Urology Department, Hospital de Calella, Barcelona 08370, Spain.
  • Reddy EP; Oncological Sciences Department. Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Fatatis A; Pharmacology and Physiology Department, Drexler University, Philadelphia, PA 19104, USA.
  • Petrylak DP; Medical Oncology Department, Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, CT 06520, USA.
  • Gomella L; Urology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Kelly WK; Cancer Biology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA; Medical Oncology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA; Urology Department, Sidney Kimmel Cancer Center, Thomas Jefferson Univ
  • Lowe SW; Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Knudsen KE; Cancer Biology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA; Medical Oncology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA; Urology Department, Sidney Kimmel Cancer Center, Thomas Jefferson Univ
  • Galsky MD; Medical Oncology Department, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Cingolani G; Department of Biochemistry and Molecular Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Lujambio A; Oncological Sciences Department. Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Division of Liver Diseases, Medicine Department, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Hoshida Y; Liver Tumor Translational Research Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Domingo-Domenech J; Cancer Biology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA; Medical Oncology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA; Pathology Department, Icahn School of Medicine at Mount Sinai, New Yor
Cell ; 174(5): 1200-1215.e20, 2018 08 23.
Article em En | MEDLINE | ID: mdl-30100187
ABSTRACT
Nuclear pore complexes (NPCs) regulate nuclear-cytoplasmic transport, transcription, and genome integrity in eukaryotic cells. However, their functional roles in cancer remain poorly understood. We interrogated the evolutionary transcriptomic landscape of NPC components, nucleoporins (Nups), from primary to advanced metastatic human prostate cancer (PC). Focused loss-of-function genetic screen of top-upregulated Nups in aggressive PC models identified POM121 as a key contributor to PC aggressiveness. Mechanistically, POM121 promoted PC progression by enhancing importin-dependent nuclear transport of key oncogenic (E2F1, MYC) and PC-specific (AR-GATA2) transcription factors, uncovering a pharmacologically targetable axis that, when inhibited, decreased tumor growth, restored standard therapy efficacy, and improved survival in patient-derived pre-clinical models. Our studies molecularly establish a role of NPCs in PC progression and give a rationale for NPC-regulated nuclear import targeting as a therapeutic strategy for lethal PC. These findings may have implications for understanding how NPC deregulation contributes to the pathogenesis of other tumor types.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Fatores de Transcrição / Glicoproteínas de Membrana / Proteínas Proto-Oncogênicas c-myc / Poro Nuclear / Fator de Transcrição E2F1 Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Fatores de Transcrição / Glicoproteínas de Membrana / Proteínas Proto-Oncogênicas c-myc / Poro Nuclear / Fator de Transcrição E2F1 Tipo de estudo: Prognostic_studies Limite: Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article